Up-to-the-Minute Myeloma News


The International Myeloma Foundation Is Creating an Award-Winning Tool for Nurses to Improve Myeloma Patient Outcomes in Underserved Communities The International Myeloma Foundation (IMF) is pleased to announce that the organization has been selected as the winner of the 2023 Sanofi HealthEquity Accelerator Award for its Shared Decision-Making among African American and Hispanic Myeloma Patients program. The IMF is developing this program and its tools to empower nurses with novel ideas and technology to improve trust and engagement in treatment decisions with African American and Hispanic patients throughout the United States. A program like this is crucial because it tackles issues of disparities and lack of access to care in African American and Hispanic American communities.


Register Now for the November 4th M-Power Community Workshop in Detroit At this M-Power Community Workshop, myeloma experts will discuss health empowerment and multiple myeloma awareness in the African American community. Check-in begins at 9:30 a.m. EST at Tabernacle Missionary Baptist Church (2080 W Grand Blvd) in Detroit. The workshop will take place from 10:00 a.m. to 12:30 p.m. EST, with refreshments provided.


Around the Web: Myeloma News To keep you abreast of the most recent myeloma research findings, “The Myeloma Minute” will now feature links to top myeloma content around the web. For this week, we encourage you to explore this article in Nature Medicine on “Elranatamab in relapsed or refractory multiple myeloma: the MagnetisMM-1 phase 1 trial.” Also in myeloma news, many reports have covered the impact of Type 2 diabetes diagnoses on myeloma patients, including this one and this one. Hematology Advisor features an article on palliative radiotherapy linked to pain response in myeloma. Finally, read this article on Racial and ethnic differences in clinical outcomes among multiple myeloma patients treated with CAR T-cell therapy. You can always learn more about myeloma news at the IMF Newsroom at the button below.


Keep Up with IMF Support Groups Support groups empower patients and care partners with information, insight, and hope. The IMF provides educational guidance to a network of more than 150 myeloma-specific groups. We are happy to connect you with other survivors and care partners, through an existing support group or by forming a new one. We also have a Spanish-language support group, Las Voces de Mieloma, that meets virtually. Finally, if there is not a Support Group in your area, contact IMF Vice President of Support Groups Robin Tuohy at [email protected] or 203-206-3536.


Medicare Open Enrollment Period Now Active Medicare's Open Enrollment Period is October 15 - December 7. This timeframe is your chance to explore Medicare Plans and see what works for you. Plans can change from year to year, and your health needs may change, too. The International Myeloma Foundation and our InfoLine team do not have recommendations about Medicare. We do, however, encourage you to explore Medicare.gov, or contact your local State Health Insurance Assistance Program (SHIP) to get the phone number for Medicare assistance for your state.


#ASKDRDURIE \| Dr. Durie's Weekly Web Video Series What is the IMF's Black Swan Research Initiative's (BSRI) Impact so far?

Week in Review Blogs by Dr. Durie

Ask Dr. Durie Videos

Online Patient Forum

Smart Patients: Join the Conversation

Clinical Trial Fact Sheets

Phase II Relapsed or Refractory Venetoclax Trial (Fully Accrued)

CANOVA Trial (Fully Accrued)

Phase I/II Trial Using a Venetoclax Combination With or Without Bortezomib (Fully Accrued)

IKEMA Trial (Fully Accrued)

IMROZ Trial (Fully Accrued)

BOSTON Trial (Fully Accrued)

Webinar Replays

Watch the Replay
M-Power Tampa

Watch the Replay
IMF Patient and Family Seminar

Watch the Replay
IMF Virtual Regional Community Workshop

See also, all of our events.

We Thank Our Sponsors:

AbbVie, Bristol Myers Squibb, GSK, Janssen Oncology, Karyopharm Therapeutics,
Pfizer, Sanofi, and Takeda Pharmaceuticals U.S.A., Inc.

We also thank individuals like you for your continued support!

Join the conversation at The International Myeloma Foundation

Facebook: /Myeloma | Twitter @IMFMyeloma | Instagram @IMFmyeloma

www.myeloma.org

This email was sent to by:
The International Myeloma Foundation
4400 Coldwater Canyon Ave., Suite 300
Studio City, CA 91604
Connect with the IMF InfoLine
1-800-452-2873

We respect your privacy and your preferences for communications of this nature.
Home • Unsubscribe • Manage Subscriptions • Privacy Policy

View as web page